Triple-negative breast cancer (TNBC) is characterized by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor 2 (HER2) [1]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.